Responsive image

Common name

[(1R,2S,4S)-norbornan-2-yl]methanol

IUPAC name

[(1R,2S,4S)-norbornan-2-yl]methanol

SMILES

C1(C2CC(C1)CC2)CO

Common name

[(1R,2S,4S)-norbornan-2-yl]methanol

IUPAC name

[(1R,2S,4S)-norbornan-2-yl]methanol

SMILES

C1(C2CC(C1)CC2)CO

INCHI

InChI=1S/C8H14O/c9-5-8-4-6-1-2-7(8)3-6/h6-9H,1-5H2/t6-,7+,8+/m0/s1

FORMULA

C8H14O

Responsive image

Common name

[(1R,2S,4S)-norbornan-2-yl]methanol

IUPAC name

[(1R,2S,4S)-norbornan-2-yl]methanol





Molecular weight

126.196

clogP

1.704

clogS

-0.915

Frequency

0.0003





HBond Acceptor

1

HBond Donor

1

Total Polar
Surface Area

20.23

Number of Rings

2

Rotatable Bond

1

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00672 Biperiden Responsive image Antiparkinson Agents; Muscarinic Antagonists; Parasympatholytics; Antidyskinetics; Nervous System; Anti-Parkinson Drugs; Anticholinergics; Tertiary Amines; CYP2D6 Inducers; CYP2D6 Inducers (strong); For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4xnw_ligand_2_6.mol2 4xnw 0.933333 -6.07 O[C@H]1CC[C@@H]2[C@@]1(C)C2 8
4xnw_ligand_2_11.mol2 4xnw 0.933333 -5.89 C([C@]12CCC[C@H]1C2)O 8
2zmj_ligand_3_17.mol2 2zmj 0.928571 -8.31 C1[C@H]2C[C@H]3C[C@@]1(C[C@H](C3)C2)C[C@@H](C)O 14
2zmj_ligand_2_13.mol2 2zmj 0.928571 -7.94 C1[C@H]2C[C@H]3C[C@@]1(C[C@H](C3)C2)CCO 13
4mm7_ligand_2_0.mol2 4mm7 0.928571 -7.38 C(C1(CCCCC1)O)C 9
1fq4_ligand_4_1490.mol2 1fq4 0.928571 -7.24 [C@@H](O)(C)CCC1CCCCC1 11
1fq7_ligand_4_2990.mol2 1fq7 0.928571 -7.23 C(C[C@@H](O)C)C1CCCCC1 11
184 , 19